Analysis
Ensuring safe and effective drugs: who can do what it takes?
BMJ 2011; 342 doi: https://doi.org/10.1136/bmj.c7258 (Published 11 January 2011) Cite this as: BMJ 2011;342:c7258Related articles
- Research Published: 06 January 2011; BMJ 342 doi:10.1136/bmj.c7153
- Editor's Choice Published: 12 January 2011; BMJ 342 doi:10.1136/bmj.d212
- Feature Published: 08 December 2009; BMJ 339 doi:10.1136/bmj.b5387
- Editorial Published: 28 April 2011; BMJ 342 doi:10.1136/bmj.d2627
- Analysis Published: 06 September 2011; BMJ 343 doi:10.1136/bmj.d4849
- Research Methods & Reporting Published: 03 January 2012; BMJ 344 doi:10.1136/bmj.d8013
- Analysis Published: 17 January 2012; BMJ 344 doi:10.1136/bmj.d7898
- Research Published: 09 April 2014; BMJ 348 doi:10.1136/bmj.g2545
- Research Published: 04 June 2014; BMJ 348 doi:10.1136/bmj.g3510
- Letter Published: 27 September 2011; BMJ 343 doi:10.1136/bmj.d6134
See more
- By not publishing good qualitative research The BMJ is not fulfilling its valuesBMJ March 15, 2016, 352 i1478; DOI: https://doi.org/10.1136/bmj.i1478
- Qualitative research and The BMJBMJ February 10, 2016, 352 i641; DOI: https://doi.org/10.1136/bmj.i641
- Case for cultural adaptation of psychological interventions for mental healthcare in low and middle income countriesBMJ December 16, 2014, 349 g7636; DOI: https://doi.org/10.1136/bmj.g7636
- Preventing bad reporting on health researchBMJ December 10, 2014, 349 g7465; DOI: https://doi.org/10.1136/bmj.g7465
- Diabetes UK responds to comments by Asimakopoulou and colleaguesBMJ January 29, 2014, 348 g1152; DOI: https://doi.org/10.1136/bmj.g1152
Cited by...
- The evidence base for new drugs
- Benefits and harms in clinical trials of duloxetine for treatment of major depressive disorder: comparison of clinical study reports, trial registries, and publications
- Oseltamivir for influenza in adults and children: systematic review of clinical study reports and summary of regulatory comments
- Clinical study reports of randomised controlled trials: an exploratory review of previously confidential industry reports
- Strengthening and Opening Up Health Research by Sharing Our Raw Data
- Rethinking credible evidence synthesis
- Out of sight but not out of mind: how to search for unpublished clinical trial evidence
- Missing clinical trial data
- No comparative drug efficacy without legislation
- Evidence of comparative efficacy should have a formal role in European drug approvals
- A theme issue in 2011 on unpublished evidence
- Access to clinical trial data